GCC Biosimilar Market 2023-2028: Share, Size, Upcoming Trends, Growth, Industry Analysis, Demand, Regional Analysis and Forecast | Syndicated Analytics

Food & Beverages

GCC Biosimilar Market: Market Size, Share, Trends, Industry Analysis, Application Analysis, Growth and Forecast, 2023-2028” provides a deep and thorough evaluation of the GCC biosimilar market based on its segments including molecule, type of manufacturing, indication, and region. The report tracks the latest industry trends and analyses their overall impact on the market. It also evaluates the market dynamics, which cover the key demand and price indicators, and studies the market on the basis of the SWOT and Porter’s Five Forces models.

Report Metrics
Historical Year: 2017-2022
Base Year: 2022
Forecast Year: 2023-2028

Download a free sample report to get detailed insight about the market: https://www.syndicatedanalytics.com/request?type=report&id=804&flag=B

A biosimilar refers to a biopharmaceutical drug that is almost similar to a reference biologic drug in terms of quality, function, safety, and efficacy. These drugs can only be produced if the patent of the reference product has expired. It is manufactured using biological substances, such as plant or animal cells and microorganisms. Biosimilar drugs are widely used to prevent, determine and treat several medical conditions and manufacture monoclonal antibodies, vaccines, and therapeutic proteins. These drugs are gaining wide traction across the GCC region as they are highly effective for medical use with no major difference.

Note: The study incorporates COVID-19’s direct market impact as well as the indirect effects of related industries on the GCC biosimilar market. These insights are regularly updated by the subject matter experts at Syndicated Analytics

GCC Biosimilar Market Industry Trends and Drivers:

The growing number of patent expiration of various blockbuster biologic drugs is primarily driving the GCC biosimilar market. Moreover, the expanding geriatric population and the increasing prevalence of chronic disorders, such as autoimmune diseases, cancer, diabetes, etc., are also contributing to the market growth. In addition to this, the escalating adoption of biosimilars, owing to their economical prices, is acting as another significant growth-inducing factor. Furthermore, numerous regional pharmaceutical companies are forming strategic alliances and collaborations with international medical research institutes to gain a competitive advantage in the development, manufacturing, or commercialization of their products, which is creating a positive outlook for the market. Additionally, the introduction of favorable government policies to accelerate the clinical trials and approvals of biosimilar drugs is propelling the market growth. Moreover, various cost-saving initiatives undertaken by government bodies of the GCC nations are encouraging the usage of biosimilars over branded biologics. This, in turn, is also expected to cater to the growth of the GCC biosimilar market over the forecasted period.

Browse complete report with tables of contents and list of figures & tables: https://www.syndicatedanalytics.com/gcc-biosimilar-market

GCC Biosimilar Market Report Scope
Report Coverage Details
Base year for estimation 2022
Historical data 2017-2022
Forecast period 2023-2028
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Molecule, Type of Manufacturing, Indication, Region
Regional scope Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman, Bahrain
Customization Scope In case our report does not include the required data, you can reach out to our analysts for customization per your needs.
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 2999
Corporate License: US$ 3999
Post-Sale Analyst Support You can reach out to our team for any post purchase support for a period of 10-12 weeks
Delivery Format Sent in PDF and Excel formats via email. (The editable version of the study in PPT/Word format can also be provided on special request.)

 GCC Biosimilar Market Segmentation:

 The market is segmented on the basis of molecule, type of manufacturing, indication, and region.

Segmentation by Molecule:

  • Infliximab
  • Insulin Glargine
  • Epoetin Alfa
  • Etanercept
  • Filgrastim
  • Somatropin
  • Rituximab
  • Follitropin Alfa

Segmentation by Type of Manufacturing:

  • In-house Manufacturing
  • Contract Manufacturing

Segmentation by Indication:

  • Auto-Immune Diseases
  • Blood Disorder
  • Diabetes
  • Oncology
  • Growth Deficiency
  • Female Infertility

Segmentation by Country:

  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Kuwait
  • Oman
  • Bahrain

Competitive Landscape:

The report also provides insights on the competitive landscape of the biosimilar market with the leading players profiled in the report.

Related Reports:

POS Terminals Market

Portable Water Purification Systems Market

Packaging Market

Microdisplay Market

Discover how this report can help boost your revenues:

  • Examine the current trends in the GCC biosimilar market to evaluate industry prospects
  • Analyze the present and future performance in established and emerging markets
  • Evaluate market dynamics and expansion opportunities
  • Investigate the economic and non-economic factors influencing market segments
  • Employ qualitative and quantitative market analysis to enhance data-driven decisions
  • Analyze how demand and supply factors influence industry growth at the regional and country level
  • Study the market competition as per Porter’s five forces model
  • Gain insights to new product launches and growth strategies employed by market players
  • Capitalize on comprehensive profiles of major companies operating in the industry

About us: Syndicated Analytics is a market research firm that offers consulting services and provides comprehensive market intelligence in the form of research reports. Our team, consisting of experienced researchers and analysts from diverse industries, is deeply committed to the quality of the information and insights delivered to the clients which range from small and medium enterprises to Fortune 1000 companies. They are able to achieve this by studying the qualitative and quantitative aspects of the market as well as staying up to date with the current and evolving trends of the industry. Our set of syndicated as well as customized market reports thus help the clients to gain a better view of their competitive landscape, overcome various industry-related challenges and formulate revenue-generating business strategies.

Contact Info:

Katherine Shields

Senior Sales & Marketing Manager

74 State St

Albany, New York 12207

United States of America

Phone No.: +1-213-316-7435

Email Address: sales@syndicatedanalytics.com

Leave a Reply